Sign Out
Levofloxacin is indicated as a treatment for adult (≥18 yo) with mild, moderate to severe infection caused by susceptible bacteria.
Acute bacterial sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Acute exacerbation from chronic bronchitis caused by Streptococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis.
Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Eschericia coli, Klebsiella pneumoniae, Haemophilus influenzae or Streptococcus pneumoniae. Additional therapy should be performed if there is clinical indication. Pseudomonas aeruginosa is considered as pathogenic bacteria, it is recommended to combine anti-pseudomonas therapy with beta-lactam groups.
Pneumonia community acquired caused by methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophilla, or Mycoplasma pneumoniae.
Multi Drug Resistant (MDR) Streptococcus pneumoniae which is isolated from strains of bacteria resistant to 2 or more of the following antibiotics: penicillin, second generation of cephalosporins such as cefuroxime, tetracycline, macrolide, and trimethoprim/sulfamethoxazole.
Chronic bacterial prostatitis caused by Eschericia coli, Enterococcus faecalis, or Staphylococcus epidermidis.
Complicated skin infections; Complicated urinary tract infection; Acute pyelonephritis.
